Hot penny stocks... don't get burned
   

News for Vertex Pharmaceutical (VRTX)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Vertex Pharmaceuticals Inc.  (VRTX) 
|
$ 27.88      -1.22 (-4.19%) Volume: 5.43 m 4:00 PM EDT Oct 6, 2008
After Hours:  $ 27.85   -0.03 (-0.11%) Volume: 700 6:10 PM EDT Oct 6, 2008
Wed, Oct 01, 2008
4:15 PM Vertex Pharmaceuticals Announces Webcast of its Presentation at the JMP Securities Healthcare Focus Conference - Business Wire
Wed, Sep 24, 2008
10:01 AM Vertex Pharmaceuticals Announces Correction to Abstract Data Published in October 2008 Supplement to Hepatology - Business Wire
8:12 AM Telaprevir Presentations at the 59th AASLD Meeting to Feature SVR Data in Treatment-Naive and Treatment-Failure Genotype 1 HCV Patients, and Clinical Data Exploring Twice-Daily Dosing Regimens - Business Wire
Mon, Sep 22, 2008
8:48 AM Vertex Pharmaceuticals Announces Exercise of Option to Purchase Additional Shares - Business Wire
Fri, Sep 19, 2008
4:27 PM Vertex Pharmaceuticals Announces Webcast of its Presentation at the UBS 2008 Global Life Sciences Conference - Business Wire
Thu, Sep 18, 2008
8:46 AM Vertex Pharmaceuticals Announces Pricing of its Public Offering of Common Stock - Business Wire
Wed, Sep 17, 2008
5:17 PM Vertex Pharmaceuticals Announces Proposed Public Offering of Common Stock - Business Wire
Thu, Sep 04, 2008
4:18 PM Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences - Business Wire
Fri, Aug 29, 2008
9:17 AM Vertex Pharmaceuticals Announces Webcast of its Presentation at the Thomas Weisel Partners Healthcare Conference 2008 - Business Wire
Tue, Aug 19, 2008
7:30 AM Vertex Pharmaceuticals to Start Phase 3 'REALIZE' Trial with Telaprevir in Treatment-Failure HCV Patients - Business Wire
Fri, Aug 08, 2008
4:16 PM Vertex Pharmaceuticals Announces Webcast of its Presentation at the Canaccord Adams 28th Annual Global Growth Conference - Business Wire
Tue, Aug 05, 2008
9:51 AM Vertex Pharmaceuticals Announces Webcast of its Presentation at the 2008 BMO Capital Markets Focus on Healthcare Conference - Business Wire
Thu, Jul 31, 2008
4:37 PM Vertex Pharmaceuticals Highlights Telaprevir Progress and Reports Second Quarter 2008 Results - Business Wire
Thu, Jul 17, 2008
9:22 AM Vertex Pharmaceuticals Announces the Date of its Second Quarter 2008 Financial Results Conference Call and Webcast - Business Wire
Wed, Jun 18, 2008
8:43 AM Vertex Pharmaceuticals Announces the Appointment of Freda C. Lewis-Hall, M.D., as Executive Vice President, Medicines Development - Business Wire
Mon, Jun 09, 2008
7:35 AM Vertex Reports 52% SVR 12 Rate for a 24-week Telaprevir-based Regimen in Genotype 1 Hepatitis C Patients Who Failed Prior Treatment - Business Wire
Fri, Jun 06, 2008
4:05 PM Vertex Pharmaceuticals Announces Webcast of its Presentation at the Goldman Sachs 29th Annual Global Healthcare Conference - Business Wire
Tue, Jun 03, 2008
8:52 AM Vertex Pharmaceuticals Sells HIV Product Royalty Stream for $160 Million - Business Wire
Fri, May 16, 2008
4:15 PM Vertex Pharmaceuticals Announces Webcast of its Presentation at the 2008 Citi Investment Research Global Healthcare Conference - Business Wire
Thu, May 15, 2008
11:23 AM Stockholders of Vertex Pharmaceuticals Approve Proxy Proposals at Annual Meeting - Business Wire
Mon, May 12, 2008
4:30 PM CORRECTING and REPLACING Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences - Business Wire
Tue, May 06, 2008
4:27 PM Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences - Business Wire
Thu, May 01, 2008
4:29 PM Vertex Pharmaceuticals Announces Webcast of its Presentation at the Deutsche Bank 33rd Annual Health Care Conference - Business Wire
Mon, Apr 28, 2008
9:47 AM Vertex Pharmaceuticals Announces Webcast of its Presentation at the 2008 Morgan Stanley Global Healthcare Unplugged Conference - Business Wire
Thu, Apr 24, 2008
12:23 PM BellwetherReport.com Initiates Analyst Coverage on PLXS, VRTX, SPAR and WAVE - Marketwire
  Page 1 of 3   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for VRTX stock. Download VRTX report.
Research Report
Get the full report for FREE
Date:Sep 3, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download VRTX report
  
Example preview: Research report for Vertex Pharmaceutical (VRTX) Research report for Vertex Pharmaceutical (VRTX) Research report for Vertex Pharmaceutical (VRTX) Research report for Vertex Pharmaceutical (VRTX)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

Hot Green Energy Stock from China


From: OTC Journal
Added: 16 Sep, 2008

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Vertex Pharmaceutical
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.